- Filed
- Mar 31, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Mar 31, 2023 | 90.48M sh |
| Cash And Equivalents | FY 2023 · Dec 31, 2022 | $477.99K |
| Cash And Equivalents | FY 2023 · Dec 31, 2021 | $258.71K |
| Shares Diluted | FY 2023 · Dec 31, 2021 | 119.31M sh |
| Capex | FY 2023 · Dec 31, 2021 | $94.41K |
| Operating Cash Flow | FY 2023 · Dec 31, 2021 | $2.16M |
| Current Liabilities | FY 2023 · Dec 31, 2021 | $3.24M |
| Current Assets | FY 2023 · Dec 31, 2021 | $1.14M |
| Total Assets | FY 2023 · Dec 31, 2021 | $5.58M |
| Eps Diluted | FY 2023 · Dec 31, 2021 | $0.00 |
| Eps Basic | FY 2023 · Dec 31, 2021 | $0.00 |
| Sga Expense | FY 2023 · Dec 31, 2021 | $2.54M |
| Net Income | FY 2023 · Dec 31, 2021 | $212.37K |
| Operating Income | FY 2023 · Dec 31, 2021 | −$22.44K |
| Gross Profit | FY 2023 · Dec 31, 2021 | $6.74M |
| Cost Of Revenue | FY 2023 · Dec 31, 2021 | $8.44M |
| Revenue | FY 2023 · Dec 31, 2021 | $15.17M |
| Stockholders Equity restated | FY 2023 · Dec 31, 2020 | −$1.93M |